FONTI, CRISTINA
FONTI, CRISTINA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial
2021 Zanoni L.; Bianchi L.; Nanni C.; Pultrone C.; Giunchi F.; Bossert I.; Matti A.; Schiavina R.; Fiorentino M.; Romagnoli D.; Fonti C.; Lodi F.; D'Errico A.; Brunocilla E.; Porreca A.; Fanti S.
The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis.
2021 Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S.
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy
2019 Zanoni L.; Varani S.; Attard L.; Morigi J.J.; Vanino E.; Ortalli M.; Fonti C.; Viale P.; Re Carla.; Fanti S.; Ambrosini V.
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.
2019 Ceci F, Castellucci P, Graziani T, Farolfi A, Fonti C, Lodi F, Fanti S.
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial
2019 Zanoni L, Broccoli A, Lambertini A, Pellegrini C, Stefoni V, Lodi F, Fonti C, Nanni C, Zinzani PL, Fanti S
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial | Zanoni L.; Bianchi L.; Nanni C.; Pultrone C.; Giunchi F.; Bossert I.; Matti A.; Schiavina R.; Fio...rentino M.; Romagnoli D.; Fonti C.; Lodi F.; D'Errico A.; Brunocilla E.; Porreca A.; Fanti S. | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis. | Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schia...vina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-01575-v3.pdf; cancers-13-01575-s001.pdf |
| 18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy | Zanoni L.; Varani S.; Attard L.; Morigi J.J.; Vanino E.; Ortalli M.; Fonti C.; Viale P.; Re Carla....; Fanti S.; Ambrosini V. | 2019-01-01 | ANNALS OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| 68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. | Ceci F, Castellucci P, Graziani T, Farolfi A, Fonti C, Lodi F, Fanti S. | 2019-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial | Zanoni L, Broccoli A, Lambertini A, Pellegrini C, Stefoni V, Lodi F, Fonti C, Nanni C, Zinzani PL..., Fanti S | 2019-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |